Gullik Håkan Wickholm
Direttore/Membro del Consiglio presso Beactica Therapeutics AB
Posizioni attive di Gullik Håkan Wickholm
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Beactica Therapeutics AB
 Beactica Therapeutics AB Medical DistributorsDistribution Services Beactica Therapeutics AB operates as a drug discovery company, utilizing its proprietary methodologies to evaluate the interactions of molecules in order to generate novel therapeutics. The firm's services include fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate analysis, competition analysis, and antibody interaction analysis. The company was founded by Per K?llblad and Ulla Helena Danielson in 2006 and is headquartered in Uppsala, Sweden. | Direttore/Membro del Consiglio | 01/01/2018 | - |
| GHW Consulting AB | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Gullik Håkan Wickholm
Precedenti posizioni note di Gullik Håkan Wickholm
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| AstraZeneca AS | Corporate Officer/Principal | - | - |
| GENOVIS AB | Direttore/Membro del Consiglio | 01/01/2019 | - |
| LYTIX BIOPHARMA | Amministratore Delegato | 01/01/2014 | 07/09/2017 |
| Corporate Officer/Principal | 07/09/2017 | - |
Formazione di Gullik Håkan Wickholm
| University of Uppsala | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Svezia | 5 |
| Norvegia | 3 |
Posizioni
| Director/Board Member | 3 |
| Corporate Officer/Principal | 2 |
| Chief Executive Officer | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
| Distribution Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| LYTIX BIOPHARMA | Health Technology |
| GENOVIS AB | Health Technology |
| Aziende private | 3 |
|---|---|
| AstraZeneca AS | |
Beactica Therapeutics AB
Beactica Therapeutics AB Medical DistributorsDistribution Services Beactica Therapeutics AB operates as a drug discovery company, utilizing its proprietary methodologies to evaluate the interactions of molecules in order to generate novel therapeutics. The firm's services include fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate analysis, competition analysis, and antibody interaction analysis. The company was founded by Per K?llblad and Ulla Helena Danielson in 2006 and is headquartered in Uppsala, Sweden. | Distribution Services |
| GHW Consulting AB |
